94 related articles for article (PubMed ID: 6525604)
1. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
Thongprasert S; Bosl GJ; Geller NL; Wittes RE
Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
[No Abstract] [Full Text] [Related]
2. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
[TBL] [Abstract][Full Text] [Related]
3. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
[No Abstract] [Full Text] [Related]
4. [Phase II trial of mitoguazone in patients with recurrent extensive cervicofacial tumors].
Coninx P; Nasca S; Jezekova D; Roelandt H; Morel M; Legros M; Cattan A
Bull Cancer; 1985; 72(2):153-4. PubMed ID: 4005436
[No Abstract] [Full Text] [Related]
5. Phase II trial of methyl-GAG in advanced renal cancer.
Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
[No Abstract] [Full Text] [Related]
6. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
[No Abstract] [Full Text] [Related]
7. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer.
Chapman R; Kelsen D; Gralla R; Itri L; Casper E; Young C; Golbey R
Cancer Clin Trials; 1981; 4(4):389-91. PubMed ID: 6274532
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
[No Abstract] [Full Text] [Related]
10. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
Knight WA; Drelichman A; Fabian C; Bukowski RM
Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631
[No Abstract] [Full Text] [Related]
11. Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
Knight WA; Loesch DM; Leichman LP; Fabian C; O'Bryan RM
Cancer Treat Rep; 1982 Dec; 66(12):2099-100. PubMed ID: 7139653
[No Abstract] [Full Text] [Related]
12. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
[TBL] [Abstract][Full Text] [Related]
13. Inefficacy of methylglyoxal bis(guanylhydrazone) (MGBG) in patients with recurrent head and neck squamous cell carcinoma.
Arteaga CL; Clark GM
Invest New Drugs; 1989 Jul; 7(2-3):281-3. PubMed ID: 2793385
[No Abstract] [Full Text] [Related]
14. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
Todd RF; Garnick MB; Canellos GP
Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
[No Abstract] [Full Text] [Related]
15. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
Todd RF; Garnick MB; Canellos GP; Richie JP; Gittes RF; Mayer RJ; Skarin AT
Cancer Treat Rep; 1981; 65(1-2):17-20. PubMed ID: 7226167
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of mitoguazone in patients with refractory germ cell tumors.
Chun H; Bosl GJ
Cancer Treat Rep; 1985 Apr; 69(4):461-2. PubMed ID: 2986835
[No Abstract] [Full Text] [Related]
17. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
[TBL] [Abstract][Full Text] [Related]
18. Methyl-GAG in advanced renal cell carcinoma.
Child JA
Prog Clin Biol Res; 1982; 100():663-7. PubMed ID: 7145994
[No Abstract] [Full Text] [Related]
19. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
20. Phase II trial of mitogauzone in malignant primary brain tumors.
Feun LG; Yung WK; Stewart DJ; Savaraj N; Bodey GP
Cancer Treat Rep; 1985 Mar; 69(3):329-30. PubMed ID: 3978660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
